Endometriosis: Exploring the Roles of MicroRNA-451 and MIF

Researchers hope to elucidate the disease’s pathogenesis

MicroRNA-690×380

By Warren B. Nothnick, PhD, HCLD, and Tommaso Falcone, MD, FRCSC, FACOG

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Endometriosis is a chronic, recurrent disease affecting as many as 1 in 10 of all women of reproductive age. Anti-hormonal treatment is often unacceptable, and surgery is often required to treat pelvic pain, dysmenorrhea and infertility.

The lack of adequate treatment stems largely from our poor understanding of factors that lead to the establishment and survival of endometrial stromal and glandular tissue in ectopic locations.

Debate persists over the mechanisms by which endometriosis develops, but reverse menstruation of viable endometrial tissue into the peritoneal cavity has the greatest support. One of this theory’s shortcomings is that almost all women of reproductive age exhibit some degree of retrograde menstruation, strongly suggesting that additional unidentified factors contribute to disease development and progression.

Potential microRNA role

MicroRNAs (miRNAs) are small, noncoding regulatory RNAs that regulate gene expression after transcription. The expanding field of research on miRNA strongly supports its ability to regulate multiple factors involved in cellular adhesion, proliferation and survival — cellular events essential for endometriotic lesion establishment and survival.

MicroRNA-451 (miR-451) demonstrates misexpression in endometriotic lesion tissue and may be of considerable clinical interest. In experimental disease models, miR-451 regulates several transcripts whose proteins play pivotal roles in endometriotic lesion survival; macrophage migration inhibitory factor (MIF) may be among the most important.

Studying tissue retrospectively

To assess the expression and possible function of miR-451 in endometriosis, we conducted a retrospective study of 30 women undergoing surgical treatment for endometriosis.1 Our analysis of matched eutopic (N = 30) and endometriotic (N = 43) lesion tissues from the subjects included:

Advertisement
  • Quantitative real-time polymerase chain reaction (qRT-PCR) to assess expression levels of miR-451 as well as those of MIF, CCNE and PTEN mRNA
  • Western blot analysis of MIF protein levels
  • 3’UTR reporter assays and Western blot analysis to assess the functional ability of miR-451 to regulate MIF translation in vitro
  • In vitro cell survival assays to confirm the ability of miR-451 to regulate epithelial cell proliferation

inset1

Shedding light on miR-451 function

Both MIF mRNA and protein were significantly (P < 0.05) decreased in endometriotic lesions as compared to eutopic endometrium. This finding was associated with a significant (P < 0.05) increase in miR-451 expression. Transfection of hES cells with luciferase reporter constructs for MIF revealed that miR-451 specifically bound to the 3’UTR to regulate expression.

Further, forced expression of miR-451 induced significant (P<0.05) downregulation of both MIF mRNA and protein in epithelial cells, a finding associated with a significant (P<0.05) reduction in cell survival. MIF inhibition using a specific antagonist verified that reduction of MIF contributes to epithelial cell survival.

Lastly, elevated miR-451 and reduced MIF were associated with reduced cell proliferation; CCNE1 expression was reduced and PTEN was elevated in endometriotic lesion tissue.

Thus, we propose that in the pathogenesis of endometriosis, elevated miR-451 may function to regulate MIF expression in an attempt to curtail endometriotic lesion tissue/cell survival. In contrast, lesions that express low levels of miR-451 and elevated MIF may be more apt to survive.

Ongoing research

The potential of a switch from low to elevated expression of miR-451 and the modulation of MIF expression as a mechanism to limit survival over the life span of endometriotic lesions is being explored. ✮

Advertisement

Dr. Nothnick is Professor of Molecular & Integrative Physiology and Scientific Advisor for Laboratory Animal Resources at the University of Kansas Medical Center.

Dr. Falcone is Professor and Chair of Cleveland Clinic’s Ob/Gyn & Women’s Health Institute and may be reached at 216.444.1758 or falcont@ccf.org.

  1. Graham A, Falcone T, Nothnick WB. The expression of microRNA-451 in human endometriotic lesions is inversely related to that of macrophage migration inhibitory factor (MIF) and regulates MIF expression and modulation of epithelial cell survival. Hum Reprod 2015;30(3):642-652.

Related Articles

woman with milk and lettuce
Neighborhood Factors Affect Early Pregnancy Metabolic Health

Deprivation is linked to impaired glucose intolerance and racial disparities

23-WHI-4386458 &#8211; OGI &#8211; CQD &#8211; topical treatment for VIN
Trial Shows Promise for Topical Treatment for VIN

Artesunate ointment is safe well and tolerated patients with vulvar intraepithelial neoplasia

contraception
Update on Current Contraceptive Options

A case-based discussion of efficacy, eligibility and use

OB/GYN Residents Wellness
Wellness Efforts Are Needed by OB-GYN Residents, But One Solution Does Not Fit All

Workshop curriculum was valued by some, while others would have preferred time for themselves

Cecile Ferrando MD
Pain in Transgender Men Undergoing Hysterectomy

Study finds lower incidence of endometriosis than in cisgender patients

18-OBG-1364-DesaiAccessBlastocyst-650&#215;450
Uninterrupted Culture in Time-Lapse Incubator Supports Human Embryonic Development

Large randomized study compares embryo growth kinetics and live birth rates between culture media

20-WHI-1938960 CQD WHI &#8211; Outcomes of Vaginoplasty Surgery &#8211; Ferrando_CQD Hero_650x450
Gender-Affirming Vaginoplasty: Reducing Complications

Surgeon experience is key to reducing adverse events

20-WHI-1878668-CQD-Predicting-Early-Pregnancy-Loss_Detti_CQD_650x450_A
Predicting Early Pregnancy Loss: Insights from Early, Serial Ultrasounds in Pregnancy

Introducing Laura Detti, MD, newly appointed Chair of the Department of Subspecialty Care for Women’s Health

Ad